The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study
The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study
Karen Dybkær, Eva Futtrup Maksten, Pernille From Blindum, Tarec Christoffer El‐Galaly et al.
Journal
Supportive Care in Cancer
Topics
Cancer Treatment and Pharmacology
article
The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study
Karen Dybkær, Eva Futtrup Maksten, Pernille From Blindum, Tarec Christoffer El‐Galaly, Niels Ejskjær, Lasse Jakobsen, Marianne Tang Severinsen, Mikkel Runason Simonsen, Carsten Dahl Mørch, Henrik Gregersen, Kristian Hay Kragholm, Jakob Madsen
article en
Abstract
No abstract available for this paper.
Publication Tag
Supportive Care in CancerVol. 33(3)
Institutions
Steno Diabetes Centers (DK), Aalborg University Hospital (DK), Odense University Hospital (DK), Karolinska Institutet (SE), Aalborg University (DK)
Funders
Dagmar Marshalls Fond, Danmarks Grundforskningsfond, Aalborg Universitetshospital